Bausch Health Companies Inc. (BHC)
$6.04+0.00%Close
SELLRECOVERY · day 14
Key stats
Short interest · FINRA settlement 2026-09-30
52-week IV0.0%–377.8%
- Market cap
- $2.3B
- Beta
- 0.37
- P/E (TTM)
- -2.04
- IV-%ile
- 50
- IV ATM
- 56.8%
- Short % float
- 2.54%
- Days to cover
- 4.8
- SI change
- -2.6%
- 1W
- +4.14%
- 1M
- -0.49%
- vs SPY 1W
- +2.98%
- vs SPY 1M
- -3.49%
Industry peers
FMP comparable companies · ranked by market cap
- HAEBUYHaemonetics Corporation$5.4BBULLQ 11$118.69-0.65%
- CONBUYConcentra Group Holdings Parent, Inc.$4.8BBULLQ 46$37.19+1.58%
- CPRXBUYCatalyst Pharmaceuticals, Inc.$3.9BBULLQ 20$31.49+0.00%
- BEAMBUYBeam Therapeutics Inc.$2.6BRECOVERYQ 14$25.70+4.47%
- HCMBUYHUTCHMED (China) Limited$2.5BRECOVERYQ 5$14.10+3.15%
- PRGOBUYPerrigo Company plc$2.1BRECOVERYQ 4$15.06+3.86%
- MLYSSELLMineralys Therapeutics, Inc.$2.1BCRISISQ 19$23.37+4.42%
- ALVOBUYAlvotech$2.0BRECOVERYQ -3$5.78+1.94%
- XRAYSELLDENTSPLY SIRONA Inc.$1.8BCRISISQ 2$8.83+1.61%
- ANIPSELLANI Pharmaceuticals, Inc.$1.7BRECOVERYQ 9$73.89+2.65%
Prediction markets
Kalshi · Polymarket · … linked
Loading markets…
Company news
FAQ
- What is LOPJLB’s current signal on BHC?
- LOPJLB’s latest quantitative signal on Bausch Health Companies Inc. (BHC) is SELL in a RECOVERY regime. Signals are updated daily.
- What market regime is BHC in?
- Bausch Health Companies Inc. (BHC) is currently classified in the RECOVERY HMM market regime on LOPJLB.
- What does Bausch Health Companies Inc. (BHC) do?
- Bausch Health Companies Inc., together with its associated entities, is engaged in the development, manufacturing, and commercialization of a diverse portfolio of pharmaceutical products, medical devices, and over-the-counter remedies. Its primary therapeutic focus areas include ophthalmology, digestive health, and dermatology. The enterprise conducts its operations through five principal divis…